tiprankstipranks
Trending News
More News >
Innovative Eyewear, Inc. (LUCY)
NASDAQ:LUCY
US Market

Innovative Eyewear, Inc. (LUCY) AI Stock Analysis

Compare
284 Followers

Top Page

LU

Innovative Eyewear, Inc.

(NASDAQ:LUCY)

Rating:35Underperform
Price Target:
Innovative Eyewear, Inc. receives a low stock score due to significant operational challenges, weak technical indicators, and unfavorable valuation metrics. The primary concerns are the company's inability to turn revenue growth into profitability, reliance on financing activities, and negative market momentum. These factors overshadow the positive aspect of a strong equity position, making it a high-risk investment at this time.
Positive Factors
Financial Performance
Full year 2024 revenue of $1.6M, increased 42.0% y/y and gross margin of 13.1% compared to negative gross margin in 2023 and 2022, reflecting efforts to improve costs.
Product Demand
Management noted greater than expected demand for its Lucyd Armor smart safety glass product, indicating strong market validation in the industrial and occupational safety eyewear segment.
Revenue Growth
The company launched its first line of Reebok-branded products, which is expected to contribute to revenue growth through the rest of the year.
Negative Factors
Product Launch Delay
The company's Reebok collection launches appear to be delayed, now expecting 2Q25 and 4Q25 (previously 1Q25 and a second in mid-2025).
Revenue Estimates
Revenue estimates for 2025 and 2026 are lowered due to an uncertain outlook for uptake by a major optical retailer in the near-term.
Strategy Shift
The company removed references to a near-term expectation for onboarding with a major optical group or chain, reflecting a shift in strategy.

Innovative Eyewear, Inc. (LUCY) vs. SPDR S&P 500 ETF (SPY)

Innovative Eyewear, Inc. Business Overview & Revenue Model

Company DescriptionInnovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. The company sells its products through various e-commerce and retail distribution channels. Innovative Eyewear, Inc. has a partnership with Lucyd. The company was founded in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. operates as a subsidiary of Lucyd Ltd.
How the Company Makes MoneyInnovative Eyewear, Inc. generates revenue primarily through the sale of its smart eyewear products. The company's revenue streams include direct sales to consumers through its online platform and retail partnerships, along with wholesale distribution to optical retailers. By pioneering in the smart eyewear sector, the company also engages in collaborations and partnerships with technology firms to integrate advanced features into its products, which may include licensing fees or co-marketing arrangements. Additionally, the company may leverage its technological innovations to offer premium-priced products, thereby enhancing its overall profitability.

Innovative Eyewear, Inc. Financial Statement Overview

Summary
Despite impressive revenue growth, Innovative Eyewear, Inc. is facing significant operational losses and negative cash flow trends. The company's balance sheet is strengthened by a strong equity position with no debt, but profitability remains elusive. Improving operational efficiency and achieving profitability are critical concerns.
Income Statement
20
Very Negative
The company has shown significant revenue growth from 2019 to 2024, but it is still experiencing substantial losses. The net profit margin is deeply negative, reflecting high expenses relative to revenue. The EBIT and EBITDA margins are also negative, indicating operational inefficiencies and financial instability.
Balance Sheet
35
Negative
The balance sheet shows a strong equity position with no debt, which is a positive indicator of financial prudence. However, the company has had negative stockholders' equity in the past and has only recently improved. The equity ratio is high, suggesting reliance on equity financing, but the return on equity is negative due to ongoing losses.
Cash Flow
25
Negative
The cash flow statement reveals negative operating cash flow and free cash flow, indicating poor cash generation from operations. The company is heavily reliant on financing activities to sustain its cash flow needs. The free cash flow to net income ratio is unfavorable due to persistent losses.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
1.64M1.15M659.79K690.67K57.00K
Gross Profit
215.19K-119.33K-56.29K148.25K-17.27K
EBIT
-7.92M-6.90M-5.58M-3.21M-650.89K
EBITDA
-7.62M-6.58M-5.54M-3.20M-762.22K
Net Income Common Stockholders
-7.77M-6.66M-5.68M-3.24M-768.18K
Balance SheetCash, Cash Equivalents and Short-Term Investments
7.52M4.29M3.59M79.73K27.02K
Total Assets
9.84M6.22M4.69M824.32K211.02K
Total Debt
0.000.0061.36K289.03K599.54K
Net Debt
-2.63M-4.29M-3.53M209.30K572.52K
Total Liabilities
743.17M659.94K665.46K616.80K765.85K
Stockholders Equity
9.10B5.56M4.02M207.52K-554.84K
Cash FlowFree Cash Flow
-7.01M-6.02M-3.44M-1.33M-99.30K
Operating Cash Flow
-6.74M-5.77M-3.22M-1.21M-40.26K
Investing Cash Flow
-5.16M-198.75K-219.95K-118.45K-59.04K
Financing Cash Flow
10.24M6.66M6.96M1.39M126.33K

Innovative Eyewear, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.45
Price Trends
50DMA
2.42
Positive
100DMA
3.34
Negative
200DMA
5.00
Negative
Market Momentum
MACD
0.06
Positive
RSI
43.38
Neutral
STOCH
10.70
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LUCY, the sentiment is Negative. The current price of 2.45 is below the 20-day moving average (MA) of 2.88, above the 50-day MA of 2.42, and below the 200-day MA of 5.00, indicating a neutral trend. The MACD of 0.06 indicates Positive momentum. The RSI at 43.38 is Neutral, neither overbought nor oversold. The STOCH value of 10.70 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LUCY.

Innovative Eyewear, Inc. Risk Analysis

Innovative Eyewear, Inc. disclosed 43 risk factors in its most recent earnings report. Innovative Eyewear, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Innovative Eyewear, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
54
Neutral
$5.38B3.27-45.10%3.30%16.81%0.02%
39
Underperform
$7.16M-285.79%23.65%
38
Underperform
$7.03M-388.03%1414.02%-14.78%
35
Underperform
$8.28M-132.93%41.99%47.51%
$6.93M1.3345.44%
$2.60M-1092.96%
29
Underperform
$2.48M-200.56%81.35%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
LUCY
Innovative Eyewear, Inc.
2.45
-5.92
-70.73%
PMCB
PharmaCyte Biotech
1.01
-1.20
-54.30%
EYEN
Eyenovia
2.44
-48.82
-95.24%
ALZN
Alzamend Neuro
3.24
-32.76
-91.00%
ACXP
Acurx Pharmaceuticals
0.30
-2.08
-87.39%
BJDX
Bluejay Diagnostics
1.66
-160.66
-98.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.